News
Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...
Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don't know what causes it.
Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...
The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...
While a comprehensive cure-all to these neurological conditions is unlikely, scientists are making headway into understanding their fundamental characteristics with the hope of preventing or ...
Researchers from the U.S. CDC have projected a significant rise in the number of amyotrophic lateral sclerosis (ALS) cases by ...
Neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS (amyotrophic lateral sclerosis) are debilitating conditions ...
12d
PsyPost on MSNALS breakthrough: Ashwagandha-derived drug shows promise in slowing progression of amyotrophic lateral sclerosisEvery year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...
Actor Eric Dane, known for Grey's Anatomy and Euphoria, has revealed his diagnosis with Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease. ALS affects nerve cells and muscle ...
Oral edaravone for patients with amyotrophic lateral sclerosis (ALS) is safe through a total of 144 weeks with no new safety signals observed. Among patients with amyotrophic lateral sclerosis ...
Scientists say an extract of the ancient medicinal plant a shwagandha has shown promise as a potential treatment to slow the symptoms of amyotrophic lateral sclerosis, also known as motor neurone ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results